mRNA Adjuvant Boosts Immunity, Colossal Biosciences Sparks Skepticism Over Egg Tech, Pediatric Dexmedetomidine Boosts Cognition, FSU Breakthrough Synthesizes Marine Compounds, and more...
May 20, 2026•11 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
(0:10): Breakthrough mRNA Adjuvant Boosts T-Cell Responses, Shows Promise for Cancer Immunotherapy and Infectious Disease Vaccines
(2:36): Colossal Biosciences' Moa Revival: Artificial Egg Technology Sparks Skepticism Despite Engineering Feats
(4:29): Study Reveals Pediatric Sedation with Dexmedetomidine Linked to Better Long-Term Cognitive Outcomes
(6:34): FSU Achieves Breakthrough in Synthesizing Marine Compounds for Cancer Drug Development
(9:00): Glycan Atlasing Offers Breakthrough in Early Disease Detection and Diagnosis Through Sugar Mapping
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Time
(2:36): Colossal Biosciences' Moa Revival: Artificial Egg Technology Sparks Skepticism Despite Engineering Feats
(4:29): Study Reveals Pediatric Sedation with Dexmedetomidine Linked to Better Long-Term Cognitive Outcomes
(6:34): FSU Achieves Breakthrough in Synthesizing Marine Compounds for Cancer Drug Development
(9:00): Glycan Atlasing Offers Breakthrough in Early Disease Detection and Diagnosis Through Sugar Mapping
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Time
For the best experience, listen in Metacast app for iOS or Android